Not exact matches
«
Based on the results from these
Phase 3 studies, the combination
of bictegravir and FTC / TAF could represent an important advance in triple - therapy
treatment for a broad range
of HIV patients, and we look forward to submitting regulatory applications in the U.S. and EU this year.»
The San Diego, California —
based biotech company MediciNova recently completed a
phase II trial
of a glia - inhibiting drug called ibudilast, already approved as an asthma
treatment in Japan, to relieve pain and treat withdrawal in opioid abusers.
They were interested in a
phase separation phenomenon that has been known for around 50 years, but could neither be precisely observed nor understood until now: The microstructure
of nickel -
based alloys changes under controlled ageing or heat
treatment and in the classical two -
phase microstructure new
phases are initially formed.
This guarded optimism is
based on the
phase I trial data showing an increase in overall survival
of 4 - 6 months in 11 glioblastoma multiforme patients (18 - 22 months) versus the 14 - 16 months survival typically seen with the standard
treatment.
14255: STAT3 Signaling During Chemo - Radiation for Squamous Cell Carcinoma
of the Head and Neck 14340: A
Phase II, Randomized, Open - Label, Multi-Center, Global Study
of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination with Tremelimumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma
of the Head and Neck (SCCHN) 14258: Randomized
Phase II and
Phase III Studies
of Individualized
Treatment for Nasopharyngeal Carcinoma
Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Some other gene products for
treatment of CLI have failed in the late
phases of clinical trials (for example, Sanofi's FGF -
based gene product).
The
treatment was granted priority review
based on results
of the
phase II JULIET trial, which was presented at the 59th American Society
of Hematology Annual Meeting and Exposition.
A. Whether the
treatment is offered in the hospital or on an outpatient
basis, patients and their families receive thorough support and education to prepare for all
phases of the blood and bone marrow stem cell transplant process.
Clinical Trials Research and Billing First in Human / Early
Phase PET in Oncology Case -
Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine Therapy for Hyperthyroidism: The State
of the Art Spondylodiscitis: Role
of Imaging for Diagnosis and Monitoring
Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation Alternative Payment Models and Value -
Based Health Care: Nuts and Bolts Maximal Tolerated Activity
of Radioactive Iodine for Metastatic Thyroid Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging
of Lung Inflammation Standardization
of Advanced PET / SPECT Data Acquisition and Analysis Thyroid Cancer Management: Novel Therapeutics and Management Options Targeting Radionuclide Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?
In 2009, bevacizumab (Avastin ®) was granted accelerated approval for the
treatment of GBM patients whose cancers had recurred,
based on results from two
phase II studies.
October 1, 2015 University
of Chicago researchers awarded $ 3.5 million as part
of national consortium to transform diagnosis and
treatment of psychotic disorders The National Institute
of Mental Health (NIMH) has awarded researchers from the University
of Chicago $ 3.5 million as part
of the second
phase of the Bipolar - Schizophrenia Network on Intermediate Phenotypes (B - SNIP2)-- a multi-university consortium that aims to establish a new system
of diagnosis for psychotic diseases
based on biomarkers, and guide the development
of novel therapies.
Just like a human emergency room, all
phases of treatment are determined on a case - by - case
basis.
Each selected protocol consist
of 5
phases that adjust power, pulsing, and time to deliver the most scientifically designed
treatments based on the latest laser research.
Novo Nordisk, the Danish pharmaceutical company largely dedicated to diabetes
treatment, launched a six - month diabetes awareness campaign as the latest
phase in Nordisk's
Base of the Pyramid development initiative.
The Strategic - Behavioral - Systems Intervention (SBS Intervention) for attachment -
based «parental alienation» represents a possible compromise solution to the alternative
of a complete protective separation
of the child from the pathogenic parenting
of the narcissistic / (borderline) parent during the active
phase of the child's
treatment and recovery stabilization.
Each
phase of this flexible, evidence -
based treatment is vividly detailed, from screening, assessment, and case conceptualization through acute therapy, maintenance
treatment, and periodic booster sessions.
follows the recommended guidelines for trauma
treatment, including a multi-modal and
phase based model that focuses on physical, emotional, mental and sensory issues that are interfering with the person's functioning and quality
of life and directly addresses the impact
of traumatic experiences.
The four key
treatment phases necessary for the effective
treatment and resolution
of an attachment -
based model for parental alienation
An attachment -
based model
of «parental alienation» also establishes clear
treatment parameters
based on a fundamental understanding
of the psychological processes involved, which require as the first step the child's protective separation from the pathogenic parenting
of the narcissistic / (borderline) parent during the active
phase of the child's
treatment and recovery.
These models follows the recommended guidelines for trauma
treatment, including a multi-modal and
phase based model that focuses on physical, emotional, mental and sensory issues that are interfering with the person's functioning and quality
of life and directly addresses the impact
of traumatic experiences.
The first step in treating attachment -
based «parental alienation» is to protectively separate the child from the source
of the pathogenic parenting during the active
phase of the child's
treatment and recovery.
Use
of phase -
based components outlined by the NCTSN Complex Trauma Workgroup and the 2009 recommended practice guidelines for
treatment of Complex PTSD in children by Ford and Cloitre as a framework for Life Storybook chapters and session structure.
Therapy for attachment -
based «parental alienation» REQUIRES the child's protective separation from the pathology
of the narcissistic / (borderline) parent during the active
phase of treatment and recovery stabilization from the role - reversal relationship with the narcissistic / (borderline) parent in which the child is being used as a «regulatory object» by the narcissistic / (borderline) parent for the psychopathology
of this parent.
The model is consistent with recommendations
of the Complex Trauma Working Committee and provides clinicians with a manual -
phase -
based method
of reaching
treatment goals.
STAIR / MPE is a sequential, two -
phase treatment based in a developmental model which is designed to be sensitive to the disturbances in attachment, emotion regulation, and interpersonal functioning that survivors
of childhood or chronic interpersonal violence often bring to
treatment.
In every case
of diagnosed attachment -
based «parental alienation» professionally responsible
treatment REQUIRES the child's protective separation from the pathogenic parenting
of the allied and supposedly favored narcissistic / (borderline) parent during the active
phase of the child's
treatment and recovery stabilization period.
The Herts and minds study: evaluating the effectiveness
of mentalization -
based treatment (MBT) as an intervention for children in foster care with emotional and / or behavioural problems: a
phase II, feasibility, randomised controlled trial.